Strategic Timing and Patient Selection for ICIs Prior to Liver Transplantation for HCC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Strategic Timing and Patient Selection for ICIs Prior to Liver Transplantation for HCC

Published:2024-07 Issue: Volume: Page:
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Hao Lu,Shan Dan,Xue Jisu

Publisher

Elsevier BV

Reference5 articles.

1. Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis;Rezaee-Zavareh;Journal of Hepatology,2024

2. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma;Llovet;Nat Rev Gastroenterol Hepatol,2021

3. Pretransplant use of immune checkpoint inhibitors for hepatocellular carcinoma: A multicenter, retrospective cohort study;Guo;American Journal of Transplantation,2024

4. Immunotherapy and Liver Transplantation: A Narrative Review of Basic and Clinical Data;Wassmer;Cancers (Basel),2023

5. Integrating immune check inhibitors in liver transplantation for hepatocellular carcinoma: The right time and the right patient;O’Kane;American Journal of Transplantation,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3